Prime Medicine Inc.
PRME | NASDAQ
$3.40
+$0.21 (+6.58%)
Sep 22, 2026, 12:59 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 47.45M | 64.11M | 63.03M | 71.4M | 53.8M | 91.88M | 182.48M | 117.98M | 55.6M | 94.16M | 41.57M | 43.96M | 120.58M | 133.46M | 187.62M | 47.95M | 92.24M | 164.25M | 185.42M | 200.66M |
Short-Term Investments | 47.62M | 71.39M | 114.65M | 137.03M | 47.95M | 52.38M | 7.97M | 57.55M | 107.27M | 116.56M | 80.09M | 121.36M | 87.04M | 116.06M | 106.3M | 98.72M | 88.36M | 47.02M | 84.2M | 99.26M |
Long-Term Investments | n/a | n/a | n/a | n/a | 13.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 14.69M | 14.69M | 14.69M | 13.69M | n/a | 14.06M | 14.06M | 14.06M | 13.5M | 14.28M | 14.28M | 15.31M | 15.31M | 15.14M | 15.14M | 19.11M | 18.37M | 16.93M | 15.6M | 794K |
Receivables | n/a | n/a | n/a | n/a | 120K | 17K | n/a | 55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.73M | 2.39M | 3.61M | 22.98M | 19.42M | 16.54M | 14.67M | 9.54M | 3.74M | 2.73M | 2.25M | 19.21M | 10.87M | 3.98M | 246K | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 96.8M | 137.89M | 181.29M | 231.41M | 121.29M | 163.77M | 211.89M | 246.07M | 170.8M | 217.65M | 142.98M | 184.53M | 218.49M | 253.5M | 296.62M | 148.85M | 181.61M | 211.96M | 270.58M | 300.41M |
Property-Plant & Equipment | 137.55M | 142.15M | 146.75M | 139.92M | 144.03M | 150.34M | 71.56M | 72.65M | 75.41M | 79.45M | 36.6M | 39.3M | 47.06M | 48.3M | 48.55M | 47.31M | 47.63M | 15.67M | 15.68M | 13.99M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 152.24M | 156.84M | 161.44M | 153.61M | 157.72M | 164.4M | 85.62M | 86.71M | 88.9M | 93.73M | 50.88M | 54.61M | 62.38M | 63.45M | 63.7M | 66.42M | 65.99M | 32.6M | 31.28M | 14.78M |
Total Assets | 249.04M | 294.73M | 342.73M | 385.01M | 279.01M | 328.16M | 297.51M | 332.78M | 259.71M | 311.38M | 193.85M | 239.15M | 280.87M | 316.95M | 360.31M | 215.27M | 247.6M | 244.55M | 301.86M | 315.19M |
Account Payables | 5.81M | 12.33M | 8.89M | 9.35M | 6.38M | 10.03M | 11.35M | 5.43M | 4.64M | 10.08M | 19.54M | 14.12M | 5.49M | 4.56M | 4.33M | 4.11M | 5.89M | 3.2M | 1.44M | 1.36M |
Deferred Revenue | 7.93M | 7.32M | 7.82M | 6.95M | 8.32M | 8.21M | 7.09M | 9.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 8.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 14.79M | 4.34M | 9.04M | 8.82M | 6.94M | 6.9M | 10.25M | 8.62M | 5.96M | 4.03M | 9.88M | 6.48M | 5.27M | 2.33M | 6.98M | 4.29M | 2.76M | 1.08M | 14.66M | 12K |
Total Current Liabilities | 31.69M | 36.29M | 37.45M | 35.02M | 34.11M | 34.29M | 37.96M | 37.88M | 20.75M | 24.44M | 56.42M | 39.37M | 28.72M | 23.87M | 26.71M | 22.22M | 23.83M | 12.89M | 57.98M | 9.54M |
Long-Term Debt | 103.51M | 105.97M | 108.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 74.03M | 75.78M | 76.13M | 18M | 71.56M | n/a | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 711K | n/a | n/a |
Total Long-Term Liabilities | 177.54M | 181.74M | 184.42M | 188.17M | 184.04M | 186.95M | 106.4M | 105.4M | 42.37M | 43.18M | 4.36M | 5.82M | 12.04M | 14.27M | 17.33M | 20.34M | 23.03M | 2.8M | 4.31M | 4.27M |
Total Liabilities | 209.23M | 218.03M | 221.87M | 223.19M | 218.15M | 221.24M | 144.36M | 143.28M | 63.12M | 67.62M | 60.78M | 45.19M | 40.76M | 38.15M | 44.04M | 42.56M | 46.86M | 15.69M | 62.3M | 13.81M |
Total Debt | 112.48M | 114.51M | 116.43M | 118.14M | 119.74M | 121.15M | 40.79M | 41.25M | 41.58M | 43.79M | 13.63M | 17.04M | 25.44M | 25.96M | 28.75M | 31.44M | 34.72M | 8.1M | 10.41M | 9.74M |
Book Value | 39.81M | 76.7M | 120.87M | 161.82M | 60.86M | 106.92M | 153.15M | 189.5M | 196.59M | 243.77M | 133.07M | 193.96M | 240.1M | 278.8M | 316.27M | 172.7M | 200.74M | 228.86M | 239.56M | 301.38M |
Book Value Per Share | 0.22 | 0.43 | 0.81 | 1.01 | 0.47 | 0.82 | 1.29 | 1.58 | 1.65 | 2.33 | 1.37 | 2.11 | 2.65 | 3.13 | 3.25 | 1.78 | 2.10 | 2.39 | 2.50 | 3.15 |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | n/a | 1K | 1K | 1K | 1K |
Retained Earnings | -979.59M | -937.48M | -888.35M | -842.28M | -791.69M | -739.1M | -687.21M | -644.94M | -592.42M | -537.09M | -491.33M | -425.69M | -374.98M | -332.59M | -293.2M | -253.91M | -224.56M | -195.22M | -171.38M | -108.47M |
Comprehensive Income | -9K | -1K | 82K | 33K | -10K | -15K | 1K | 21K | -71K | -95K | -15K | -149K | -268K | -205K | -384K | -454K | -150K | -32K | -27K | -9K |
Shareholders Equity | 39.81M | 76.7M | 120.87M | 161.82M | 60.86M | 106.92M | 153.15M | 189.5M | 196.59M | 243.77M | 133.07M | 193.96M | 240.1M | 278.8M | 316.27M | 172.7M | 200.74M | 228.86M | 239.56M | 301.38M |
Total Investments | 47.62M | 71.39M | 114.65M | 137.03M | 61.64M | 52.38M | 7.97M | 57.55M | 107.27M | 116.56M | 80.09M | 121.36M | 87.04M | 116.06M | 106.3M | 98.72M | 88.36M | 47.02M | 84.2M | 99.26M |
Add to Watchlist
Select watchlists to add or remove PRME